{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:39:19Z","timestamp":1767980359854,"version":"3.49.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.carrev.2005.07.004","type":"journal-article","created":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T07:17:27Z","timestamp":1128064647000},"page":"82-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Contrast-induced nephropathy: a review"],"prefix":"10.1016","volume":"6","author":[{"given":"Mohammad","family":"Sanaei-Ardekani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Reza","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrzad","family":"Movafagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrollah","family":"Ghahramani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.carrev.2005.07.004_bib1","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","author":"Rihal","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/003655900750048341","article-title":"Nephrotoxicity related to contrast media","volume":"34","author":"Berg","year":"2000","journal-title":"Scand J Urol Nephrol"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2214\/ajr.141.5.1027","article-title":"Predicting angiography-induced acute renal function impairment: clinical risk model","volume":"141","author":"Cochran","year":"1983","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.carrev.2005.07.004_bib4","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s003300050894","article-title":"Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR)","volume":"9","author":"Morcos","year":"1999","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1051-0443(07)61394-3","article-title":"Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention","volume":"12","author":"Waybill","year":"2001","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.ki.4495510","article-title":"Contrast-medium-induced acute renal failure","volume":"53","author":"Solomon","year":"1998","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM198901193200303","article-title":"Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study","volume":"320","author":"Parfrey","year":"1989","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carrev.2005.07.004_bib8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archinte.1990.00390180067011","article-title":"Incidence, risk factors and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study","volume":"150","author":"Rich","year":"1990","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1056\/NEJM198901193200304","article-title":"Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent","volume":"320","author":"Schwab","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0735-1097(98)00574-9","article-title":"A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the PRINCE Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation","volume":"33","author":"Stevens","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(83)90618-6","article-title":"Hospital-acquired renal insufficiency a prospective study","volume":"74","author":"Hou","year":"1983","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7326\/0003-4819-110-2-119","article-title":"Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial","volume":"110","author":"Davidson","year":"1989","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib14","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib15","first-page":"71","article-title":"Cardiorenal risk: an important clinical intersection","volume":"3","author":"McCullough","year":"2002","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1067\/mhj.2002.122118","article-title":"Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy","volume":"143","author":"Tumlin","year":"2002","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM200007203430311","article-title":"Acetylcysteine and nephrotoxic effects of radiographic contrast agents\u2014a new use for an old drug","volume":"343","author":"Safirstein","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib18","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1046\/j.1523-1755.2000.00012.x","article-title":"Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism","volume":"57","author":"Wang","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","article-title":"Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study","volume":"47","author":"Rudnick","year":"1995","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ki.1989.254","article-title":"Nephrotoxicity of contrast media","volume":"36","author":"Berns","year":"1989","journal-title":"Kidney Int"},{"issue":"9384","key":"10.1016\/j.carrev.2005.07.004_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(03)14189-X","article-title":"Acetylcysteine for prevention of contrast nephropathy: meta-analysis","volume":"362","author":"Birck","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine","volume":"343","author":"Tepel","year":"2000","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.carrev.2005.07.004_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.1996.03530430033035","article-title":"The effect of acute renal failure on mortality","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2214\/ajr.161.5.8273616","article-title":"Adverse reactions to contrast media: factors that determine the cost of treatment","volume":"161","author":"Powe","year":"1993","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib25","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0735-1097(00)00917-7","article-title":"The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency","volume":"36","author":"Gruberg","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.carrev.2005.07.004_bib26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM199411243312104","article-title":"Effects of saline, mannitol and furosemide, on acute decreases in renal function induced by radiocontrast agents","volume":"331","author":"Solomon","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0735-1097(10)80103-2","article-title":"A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography","volume":"17","author":"Taliercio","year":"1991","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2214\/ajr.157.1.2048540","article-title":"Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media","volume":"157","author":"Lautin","year":"1991","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.V52125","article-title":"Contrast nephrotoxicity","volume":"5","author":"Barrett","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.188.1.8511292","article-title":"Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media","volume":"188","author":"Barrett","year":"1993","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.carrev.2005.07.004_bib31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0735-1097(02)02308-2","article-title":"Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure","volume":"40","author":"Shyu","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2005.07.004_bib32","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1046\/j.1523-1755.2002.00673.x","article-title":"A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography","volume":"62","author":"Durham","year":"2002","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.162.3.329","article-title":"Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty","volume":"162","author":"Mueller","year":"2002","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0735-1097(02)01958-7","article-title":"Acetylcysteine and contrast agent-associated nephrotoxicity","volume":"40","author":"Briguori","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2005.07.004_bib35","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(03)00487-X","article-title":"A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study","volume":"41","author":"Baker","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.289.5.553","article-title":"Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial","volume":"289","author":"Kay","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0002-9149(01)02243-3","article-title":"Acetylcysteine to prevent angiography-related renal tissue injury (the APART Trial)","volume":"89","author":"Diaz-Sandoval","year":"2002","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib38","first-page":"458","article-title":"Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography","volume":"60","author":"MacNeill","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib39","first-page":"232","article-title":"Contrast-associated nephropathy: presentation, pathophysiology and management","volume":"20","author":"Porter","year":"1994","journal-title":"Miner Electrolyte Metab"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.1985.32","article-title":"A role of calcium in radiocontrast-induced reductions in renal hemodynamics","volume":"27","author":"Bakris","year":"1985","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib41","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1681\/ASN.V651451","article-title":"Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure","volume":"6","author":"Russo","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.V11118","article-title":"Oxygen and renal hemodynamics in the conscious rat","volume":"11","author":"Flemming","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib43","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ki.1991.255","article-title":"Early renal medullary hypoxic injury from radiocontrast and indomethacin","volume":"40","author":"Heyman","year":"1991","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib44","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/ki.1996.181","article-title":"Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney","volume":"49","author":"Liss","year":"1996","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0272-6386(97)90212-2","article-title":"Oxidant mechanisms in toxic acute renal failure","volume":"29","author":"Baliga","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"1 Pt 2","key":"10.1016\/j.carrev.2005.07.004_bib46","first-page":"F115","article-title":"Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals","volume":"258","author":"Bakris","year":"1990","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib47","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/ki.1992.153","article-title":"Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion","volume":"41","author":"Yoshioka","year":"1992","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.carrev.2005.07.004_bib48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00004424-198909000-00010","article-title":"Contrast media-induced lipid peroxidation in the rat kidney","volume":"24","author":"Parvez","year":"1989","journal-title":"Invest Radiol"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1523-1755.1999.00528.x","article-title":"Renal hemodynamics in radiocontrast medium-induced renal dysfunction","volume":"56","author":"Bakris","year":"1999","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.carrev.2005.07.004_bib50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00004424-199911000-00004","article-title":"Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia","volume":"34","author":"Heyman","year":"1999","journal-title":"Invest Radiol"},{"issue":"10","key":"10.1016\/j.carrev.2005.07.004_bib51","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199503093321006","article-title":"Hypoxia of the renal medulla\u2014its implications for disease","volume":"332","author":"Brezis","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/ajkd.1998.v32.pm9669426","article-title":"Oxygen free radicals and contrast nephropathy","volume":"32","author":"Katholi","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"33","key":"10.1016\/j.carrev.2005.07.004_bib53","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.carrev.2005.07.004_bib54","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI16826","article-title":"Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta","volume":"111","author":"Dada","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib55","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/bbrc.2000.3504","article-title":"Reactive oxygen intermediates are involved in IL-8 production induced by hyperosmotic stress in human bronchial epithelial cells","volume":"276","author":"Loitsch","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/bbrc.1999.1079","article-title":"Involvement of receptor aggregation and reactive oxygen species in osmotic stress-induced Syk activation in B cells","volume":"262","author":"Qin","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.carrev.2005.07.004_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0076-6879(90)86093-B","article-title":"Role of free radicals and catalytic metal ions in human disease: an overview","volume":"186","author":"Halliwell","year":"1990","journal-title":"Methods Enzymol"},{"issue":"2\u20133","key":"10.1016\/j.carrev.2005.07.004_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0005-2728(99)00021-3","article-title":"Nitric oxide and iron proteins","volume":"1411","author":"Cooper","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.carrev.2005.07.004_bib59","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1172\/JCI111364","article-title":"Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases","volume":"73","author":"Biemond","year":"1984","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-5793(78)80779-0","article-title":"Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates: is it a mechanism for hydroxyl radical production in biochemical systems?","volume":"92","author":"Halliwell","year":"1978","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/bj1980125","article-title":"Hydroxyl radical production in body fluids. Roles of metal ions, ascorbate and superoxide","volume":"198","author":"Winterbourn","year":"1981","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/bj1990263","article-title":"Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of \u201cfree\u201d iron in biological systems by using bleomycin-dependent degradation of DNA","volume":"199","author":"Gutteridge","year":"1981","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/anie.197300571","article-title":"Structure and function of ferritin","volume":"12","author":"Crichton","year":"1973","journal-title":"Angew Chem Int Ed Engl"},{"issue":"19","key":"10.1016\/j.carrev.2005.07.004_bib64","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/bi00612a021","article-title":"Mechanism and kinetics of iron release from ferritin by dihydroflavins and dihydroflavin analogues","volume":"17","author":"Jones","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.carrev.2005.07.004_bib65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ndt\/gfh565","article-title":"Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study","volume":"20","author":"Leehey","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.carrev.2005.07.004_bib66","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/ndt\/4.12.1030","article-title":"Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipinea prospective randomised clinical trial","volume":"4","author":"Neumayer","year":"1989","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib67","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/ki.1994.186","article-title":"Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application","volume":"45","author":"Erley","year":"1994","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.carrev.2005.07.004_bib68","first-page":"738","article-title":"Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures","volume":"13","author":"Shammas","year":"2001","journal-title":"J Invasive Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib69","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/ajkd.1998.v31.pm9531185","article-title":"Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy","volume":"31","author":"Kurnik","year":"1998","journal-title":"Am J Kid Dis"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0167-5273(95)02547-2","article-title":"Use of dopamine in prevention of contrast induced acute renal failure\u2014a randomised study","volume":"53","author":"Kapoor","year":"1996","journal-title":"Int J Cardiol"},{"issue":"17","key":"10.1016\/j.carrev.2005.07.004_bib71","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.290.17.2284","article-title":"Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial","volume":"290","author":"Stone","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib72","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jacc.2004.04.052","article-title":"N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity","volume":"44","author":"Briguori","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib73","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2214\/ajr.136.5.859","article-title":"Renal failure after major angiography can be avoided with hydration","volume":"136","author":"Eisenberg","year":"1981","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.1994.32","article-title":"Risk of radiocontrast nephropathy in patients with and without diabetes mellitus","volume":"45","author":"Weisberg","year":"1994","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.carrev.2005.07.004_bib75","first-page":"432","article-title":"Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency","volume":"64","author":"Hans","year":"1998","journal-title":"Am Surg"},{"issue":"Pt 3","key":"10.1016\/j.carrev.2005.07.004_bib76","first-page":"123","article-title":"Contrast media and regional renal blood flow. A study of the effects of ionic and non-ionic monomeric and dimeric contrast media in the rat","volume":"378","author":"Nygren","year":"1992","journal-title":"Acta Radiol Suppl"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib77","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ki.1979.29","article-title":"Effects of dopamine on canine intrarenal blood flow distribution during hemorrhage","volume":"15","author":"Neiberger","year":"1979","journal-title":"Kidney Int"},{"key":"10.1016\/j.carrev.2005.07.004_bib78","first-page":"211","article-title":"Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease","volume":"17","author":"Tadros","year":"2005","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2005.07.004_bib79","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1148\/radiology.198.2.8596869","article-title":"Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures","volume":"198","author":"Kaufman","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.carrev.2005.07.004_bib80","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1148\/radiology.201.2.8888260","article-title":"Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography","volume":"201","author":"Matchett","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.carrev.2005.07.004_bib81","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/ndt\/17.5.824","article-title":"Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function","volume":"17","author":"Rieger","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.carrev.2005.07.004_bib82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s003300050643","article-title":"Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography","volume":"9","author":"Hammer","year":"1999","journal-title":"Eur Radiol"},{"key":"10.1016\/j.carrev.2005.07.004_bib83","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiology.210.3.r99fe58663","article-title":"Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment","volume":"210","author":"Spinosa","year":"1999","journal-title":"Radiology"},{"issue":"18","key":"10.1016\/j.carrev.2005.07.004_bib84","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.0000146396.19081.73","article-title":"Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention","volume":"110","author":"Spargias","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2005.07.004_bib85","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0002-9343(01)00983-4","article-title":"Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful","volume":"111","author":"Vogt","year":"2001","journal-title":"Am J Med"},{"issue":"14","key":"10.1016\/j.carrev.2005.07.004_bib86","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa023204","article-title":"The prevention of radiocontrast-agent-induced nephropathy by hemofiltration","volume":"349","author":"Marenzi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2005.07.004_bib87","first-page":"F292","article-title":"N-Acetyl cysteine ameliorates ischemic renal failure","volume":"272","author":"DiMari","year":"1997","journal-title":"Am J Physiol"},{"issue":"11","key":"10.1016\/j.carrev.2005.07.004_bib88","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.4049\/jimmunol.168.11.5817","article-title":"Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney","volume":"168","author":"Cunningham","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0021-9150(95)05568-H","article-title":"Role of glutathione redox cycle in TNF-alpha-mediated endothelial cell dysfunction","volume":"117","author":"Toborek","year":"1995","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib90","first-page":"279","article-title":"Prospective randomized study of N-acetylcysteine, fenoldopam and saline for prevention of radiocontrast-induced nephropathy","volume":"57","author":"Allaqaband","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-2-38","article-title":"Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis","volume":"2","author":"Bagshaw","year":"2004","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib92","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1378\/chest.112.1.164","article-title":"A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group","volume":"112","author":"Bernard","year":"1997","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib93","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ahj.2004.01.011","article-title":"N-Acetylcysteine to prevent contrast nephropathy","volume":"147","author":"Meine","year":"2004","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib94","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.ASN.0000116241.47678.49","article-title":"N-Acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials","volume":"15","author":"Kshirsagar","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib95","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1523-1755.2004.00516.x","article-title":"Systematic review of the impact of N-acetylcysteine on contrast nephropathy","volume":"65","author":"Pannu","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.carrev.2005.07.004_bib96","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/00365519409085464","article-title":"Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine","volume":"54","author":"Hultberg","year":"1994","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib97","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ahj.2004.03.041","article-title":"A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect","volume":"148","author":"Webb","year":"2004","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.ASN.0000106780.14856.55","article-title":"The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable","volume":"15","author":"Hoffmann","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","article-title":"Clinical pharmacokinetics of N-acetylcysteine","volume":"20","author":"Holdiness","year":"1991","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"Borgstrom","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib102","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ahj.2004.05.015","article-title":"N-Acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up","volume":"148","author":"Miner","year":"2004","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib103","first-page":"382","article-title":"Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers","volume":"39","author":"De Caro","year":"1989","journal-title":"Arzneimittelforschung"},{"issue":"9","key":"10.1016\/j.carrev.2005.07.004_bib104","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2004.06.075","article-title":"Contrast nephropathy: review focusing on prevention","volume":"44","author":"Maeder","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ehj.2003.10.014","article-title":"Prevention of contrast-induced renal dysfunction by N-acetylcysteine: truth or myth?","volume":"25","author":"Billinger","year":"2004","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.carrev.2005.07.004_bib106","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2214\/ajr.181.6.1811463","article-title":"Guidelines for contrast media from the European Society of Urogenital Radiology","volume":"181","author":"Thomsen","year":"2003","journal-title":"AJR Am J Roentgenol"},{"issue":"19","key":"10.1016\/j.carrev.2005.07.004_bib107","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate a randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2005.07.004_bib108","series-title":"Handbook of methods for oxygen radical research","author":"Greenwald","year":"1985"},{"key":"10.1016\/j.carrev.2005.07.004_bib109","series-title":"Brenner & Rector's The kidney","author":"Brenner","year":"2004"},{"key":"10.1016\/j.carrev.2005.07.004_bib110","first-page":"345","article-title":"Renoprotective properties of acetazolamide in a rat model of contrast media induced renal failure","volume":"14","author":"Novikov","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.carrev.2005.07.004_bib111","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000185304","article-title":"An easy and effective procedure to prevent radiocontrast agent nephrotoxicity in high-risk patients","volume":"51","author":"Teruel","year":"1989","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.carrev.2005.07.004_bib112","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.carrev.2005.07.004_bib113","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000183915","article-title":"Effect of sodium bicarbonate preloading on ischemic renal failure","volume":"44","author":"Atkins","year":"1986","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.carrev.2005.07.004_bib114","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2362.1981.tb02122.x","article-title":"Inefficacy of bicarbonate infusions on the course of postischaemic acute renal failure in the rat","volume":"11","author":"Sporer","year":"1981","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"10.1016\/j.carrev.2005.07.004_bib115","first-page":"70","article-title":"Renal protection in the cath lad: a novel therapeutic device for high-risk patients undergoing PCI","volume":"13","author":"Minarsch","year":"2005","journal-title":"Catheter Lab Dig"},{"key":"10.1016\/j.carrev.2005.07.004_bib116","first-page":"TCT-51","article-title":"Differential effects between intravenous and local renal delivery of fenoldopam on renal function and blood pressure: a randomized, controlled trial","author":"Madyoon","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2005.07.004_bib117","first-page":"97","article-title":"Successful removal of iodine contrast from coronary sinus in swine during coronary angiography for prevention of contrast induced nephropathy. Annual Meeting American Society for Cardiac Angiography and Intervention","volume":"62","author":"Movahed","year":"2004","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838905000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838905000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:04:13Z","timestamp":1761559453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838905000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1553838905000953"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2005.07.004","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contrast-induced nephropathy: a review","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2005.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}